Table 1 Baseline characteristics
Total cohort | Body mass index (BMI) at baseline | ||||
|---|---|---|---|---|---|
BMI <25 | 25 ≤ BMI < 30 | 30 ≤ BMI < 35 | BMI ≥ 35 | ||
N (%) | 17,374 | 3,534 (20.8%) | 6,811 (40.1%) | 4,218 (24.9%) | 2,405 (14.2%) |
Age (years) | 62 ± 12 | 62 ± 12 | 62 ± 12 | 62 ± 11 | 60 ± 11 |
Male (%) | 53% | 55% | 58% | 52% | 39% |
Weight (kg) | 80.8 ± 17.6 | 62.8 ± 8.5 | 76.4 ± 9.2 | 88.6 ± 11.0 | 104.5 ± 15.6 |
BMI (kg/m2) | 29.2 ± 5.3 | 22.8 ± 1.7 | 27.4 ± 1.4 | 32.1 ± 1.4 | 38.8 ± 3.3 |
Waist circumference (cm) | 99.3 ± 15.1 | 85.3 ± 9.0 | 96.0 ± 9.7 | 107.3 ± 9.4 | 119.5 ± 12.4 |
Hip circumference (cm) | 104.0 ± 13.4 | 94.5 ± 8.0 | 102.3 ± 8.4 | 110.7 ± 9.7 | 123.3 ± 14.0 |
Waist:hip ratio | 0.94 ± 0.11 | 0.90 ± 0.09 | 0.93 ± 0.08 | 0.97 ± 0.10 | 0.98 ± 0.13 |
Blood pressure (mmHg) | |||||
Systolic | 136 ± 17 | 131 ± 16 | 135 ± 16 | 139 ± 16 | 140 ± 18 |
Diastolic | 81 ± 10 | 78 ± 9 | 81 ± 9 | 82 ± 10 | 82 ± 11 |
FBG (mmol/L) | 10.3 ± 3.1 | 9.8 ± 3.0 | 10.0 ± 2.9 | 10.4 ± 3.1 | 10.8 ± 3.1 |
HbA1c (%) | 8.9 ± 1.6 | 8.7 ± 1.8 | 8.8 ± 1.5 | 9.0 ± 1.5 | 9.1 ± 1.5 |
Lipd profile (mmol/L) | |||||
Total cholesterol | 5.1 ± 1.2 | 5.0 ± 1.1 | 5.1 ± 1.2 | 5.1 ± 1.2 | 5.0 ± 1.2 |
HDL | 1.2 ± 0.4 | 1.3 ± 0.4 | 1.2 ± 0.3 | 1.2 ± 0.4 | 1.2 ± 0.3 |
LDL | 2.9 ± 1.0 | 2.9 ± 0.9 | 3.0 ± 1.0 | 2.9 ± 1.0 | 2.8 ± 1.0 |
Triglycerides | 2.1 ± 1.2 | 1.8 ± 1.2 | 2.1 ± 1.2 | 2.2 ± 1.2 | 2.4 ± 1.2 |
Duration of Diabetes (years) | 10 ± 7 | 10 ± 8 | 10 ± 7 | 10 ± 7 | 9 ± 7 |
Duration of OHA treatment | 8 ± 7 | 9 ± 8 | 8 ± 6 | 8 ± 6 | 8 ± 7 |
Number of OHAs | |||||
1 OHA | 29.9% | 33.7% | 30.3% | 26.8% | 26.9% |
2 OHAs | 54.1% | 50.4% | 54.8% | 56.7% | 54.2% |
>2 OHAs | 16.0% | 15.8% | 14.9% | 16.5% | 18.9% |